Cardiogenomics Registry (CGR)
This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||CAD Genotype and Phenotype Cardiac Catheterization Laboratory Registry|
- To assess the relationship of multiple phenotypes and genotypes with cardiovascular disease [ Time Frame: Yearly ] [ Designated as safety issue: No ]
- To assess the impact of phenotypes and genotypes of specific patient subgroups (gender, ethnic, family history) on cardiovascular disease [ Time Frame: Yearly ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
20 mL of blood are collected and aliquots of whole blood, plasma, serum and buffy coat are stored.
|Study Start Date:||February 2006|
|Estimated Study Completion Date:||December 2020|
|Estimated Primary Completion Date:||December 2020 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00861575
|United States, Georgia|
|Atlanta, Georgia, United States, 30309|
|Principal Investigator:||Sarah Rinehart, MD||Piedmont Healthcare|